VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 224 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2023. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,261,557 | -42.0% | 132,962 | -45.0% | 0.00% | -33.3% |
| Q1 2023 | $5,620,868 | -15.4% | 241,550 | -8.0% | 0.01% | -25.0% |
| Q4 2022 | $6,642,660 | +134.4% | 262,452 | +78.5% | 0.01% | +100.0% |
| Q3 2022 | $2,834,000 | +425.8% | 146,993 | +594.2% | 0.00% | +300.0% |
| Q2 2022 | $539,000 | -74.7% | 21,174 | -74.4% | 0.00% | -50.0% |
| Q1 2022 | $2,127,000 | +189.4% | 82,710 | +371.1% | 0.00% | +100.0% |
| Q4 2021 | $735,000 | -66.5% | 17,558 | -65.1% | 0.00% | -50.0% |
| Q3 2021 | $2,192,000 | -51.6% | 50,372 | -47.4% | 0.00% | -60.0% |
| Q2 2021 | $4,528,000 | – | 95,767 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
| SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
| Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
| SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
| ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
| Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
| DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
| Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |